VTGN
VistaGen Therapeutics Inc
0.273$
-7.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | 100.0% | – | – | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | |
| – | – | 915.5% | – | – | 30.9% | – | 73.5% | – | 53.4% | 130.7% | – | |
| – | – | 100.0% | – | – | -30.9% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | |
| – | – | 416.3% | – | – | 3,989.6% | 1,094.6% | 3,193.1% | – | 1,881.8% | 8,101.9% | 4,332.1% | |
| – | – | 469.4% | – | – | 1,976.0% | 651.5% | 942.6% | – | 1,321.7% | 3,515.2% | 1,451.6% | |
| – | – | 919.9% | – | – | 5,949.5% | 1,746.1% | 4,408.7% | – | 3,203.5% | 11,617.1% | 5,783.7% | |
| – | – | -819.9% | – | – | -5,980.4% | -1,646.1% | -4,308.7% | – | -3,103.5% | -11,517.1% | -5,683.7% | |
| – | – | 0.4% | – | – | 4.5% | 1.2% | 20.9% | – | – | – | – | |
| – | – | -820.2% | – | – | -6,219.0% | -1,645.9% | -4,306.9% | – | -2,759.2% | -10,578.4% | -5,490.8% | |
| – | – | 0.2% | – | – | 0.8% | 0.2% | 0.3% | – | 0.4% | 1.4% | 0.6% | |
| – | – | -820.4% | – | – | -6,219.8% | -1,646.1% | -4,307.2% | – | -2,759.6% | -10,579.8% | -5,491.3% | |
| – | – | -781.3% | – | – | -6,183.6% | -1,600.8% | -4,242.8% | – | -2,705.8% | -10,447.7% | -5,625.9% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.